Insider Transactions in Q3 2024 at Cerevel Therapeutics Holdings, Inc. (CERE)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2024
|
Pfizer Inc |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
27,349,211
-100.0%
|
$1,230,714,495
$45.0 P/Share
|
|
Aug 01
2024
|
Christopher R Gordon |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
65,679,781
-100.0%
|
-
|
|
Aug 01
2024
|
Christopher R Gordon |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,743
-61.94%
|
-
|
|
Aug 01
2024
|
Bain Capital Investors LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
65,679,781
-100.0%
|
-
|
|
Aug 01
2024
|
Adam Koppel |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
65,679,781
-100.0%
|
-
|
|
Aug 01
2024
|
Adam Koppel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,743
-61.94%
|
-
|
|
Aug 01
2024
|
Ronald C Renaud Jr President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
83,857
-100.0%
|
-
|
|
Aug 01
2024
|
Ronald C Renaud Jr President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
160,452
-100.0%
|
-
|
|
Aug 01
2024
|
Douglas E. Giordano |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,743
-61.94%
|
-
|
|
Aug 01
2024
|
Ramiro Sanchez Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,673
-100.0%
|
-
|
|
Aug 01
2024
|
Kathleen Tregoning |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,666
-100.0%
|
-
|
|
Aug 01
2024
|
Kenneth Di Pietro Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,042
-100.0%
|
-
|
|
Aug 01
2024
|
John Renger Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,370
-100.0%
|
-
|
|
Aug 01
2024
|
Gabrielle Sulzberger |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,876
-91.12%
|
-
|
|
Aug 01
2024
|
Scott Akamine Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,527
-100.0%
|
-
|
|
Aug 01
2024
|
Ruth Mckernan |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,743
-61.94%
|
-
|
|
Aug 01
2024
|
Norbert G Riedel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
56,553
-90.75%
|
-
|
|
Aug 01
2024
|
Susan Altschuller Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,913
-100.0%
|
-
|
|
Aug 01
2024
|
Marijn E Dekkers |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
402,326
-100.0%
|
-
|
|
Aug 01
2024
|
Marijn E Dekkers |
SELL
Sale (or disposition) back to the issuer
|
Direct |
42,283
-87.63%
|
-
|
|
Aug 01
2024
|
Paul D. Burgess |
SELL
Sale (or disposition) back to the issuer
|
Direct |
45,727
-100.0%
|
-
|
|
Aug 01
2024
|
N Anthony Coles |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,928
-80.16%
|
-
|
|
Aug 01
2024
|
Deval L Patrick |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,743
-61.94%
|
-
|
|
Aug 01
2024
|
Mark Bodenrader |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,724
-100.0%
|
-
|
|
Jul 01
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
25,000
-49.09%
|
$1,025,000
$41.18 P/Share
|
|
Jul 01
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+32.93%
|
$75,000
$3.5 P/Share
|